Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShires Inc. Regulatory News (SHRS)

Share Price Information for Shires Inc. (SHRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 229.00
Bid: 230.00
Ask: 233.00
Change: 0.00 (0.00%)
Spread: 3.00 (1.304%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 229.00
SHRS Live PriceLast checked at -
Shires Income is an Investment Trust

To invest principally in the ordinary shares of UK quoted companies, and in preference shares, convertibles and other fixed income securities with above average yields.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

2 Dec 2021 07:00

RNS Number : 2757U
Shires Income PLC
02 December 2021
 

SHIRES INCOME PLC

 

HALF YEARLY FINANCIAL REPORT

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2021

Legal Entity Identifier (LEI): 549300HVCIHNQNZAYA89

 

 

INVESTMENT OBJECTIVE

The Company's investment objective is to provide shareholders with a high level of income, together with the potential for growth of both income and capital from a diversified portfolio substantially invested in UK equities but also in preference shares, convertibles and fixed income securities.

 

BENCHMARK

The Company's benchmark is the FTSE All-Share Index (total return).

 

DIVIDENDS

The Company pays dividends to Ordinary shareholders on a quarterly basis.

 

HIGHLIGHTS

 

Net asset value per Ordinary share total return A

Share price total return A

Benchmark index total return

Six months ended 30 September 2021

+12.3%

Six months ended 30 September 2021

+11.7%

Six months ended 30 September 2021

 +8.0%

Year ended 31 March 2021

+34.0%

Year ended 31 March 2021

+31.2%

Year ended 31 March 2021

+26.7%

Earnings per Ordinary share (revenue)

Dividend yield A

Discount to net asset value A

Six months ended 30 September 2021

7.21p

As at 30 September 2021

4.9%

As at 30 September 2021

 6.1%

Six months ended 30 September 2020

6.18p

As at 31 March 2021

5.3%

As at 31 March 2021

5.5%

A Considered to be an Alternative Performance Measure.

 

 

30 September 2021

31 March 2021

% change

Total assets (£'000) A

107,505

99,856

+7.7

Shareholders' funds (£'000)

88,506

80,857

+9.5

Net asset value per share

287.01p

262.41p

+9.4

Share price (mid-market)

269.50p

248.00p

+8.7

Discount to net asset value (cum-income) B

6.1%

5.5%

Dividend yield B

4.9%

5.3%

Net gearing B

20.7%

16.5%

Ongoing charges ratio B

1.17%

1.21%

A Less current liabilities excluding bank loans of £18,999,000. 

B Considered to be an Alternative Performance Measure.

 

 

PERFORMANCE (TOTAL RETURN)

 

Sixmonths ended

Yearended

Three years ended

Five years ended

30 September 2021

30 September 2021

30 September 2021

30 September 2021

Net asset value A

+12.3%

+32.2%

+22.9%

+42.3%

Share price A

+11.7%

+33.1%

+24.9%

+53.2%

FTSE All-Share Index

+8.0%

+27.9%

+9.5%

+29.8%

A Considered to be an Alternative Performance Measure.

All figures are for total return and assume reinvestment of net dividends excluding transaction costs.

 

 

For further information, please contact:

 

 

Luke Mason

Aberdeen Asset Managers Limited

0207 463 6100

 

 

CHAIRMAN'S STATEMENT

 

Market Background

The first half of the financial year was a more stable environment as the global economy continued to recover from the Covid-19 pandemic. Although we have seen spikes in case numbers in various geographies, including the UK, economic activity has picked up and, in the majority of countries, restrictions on movement and interaction have been significantly reduced compared to last year. Concerns certainly remain, especially as we enter winter in the Northern Hemisphere and the effectiveness of vaccination programmes begins to fade, but for the majority of companies the outlook is clearer than it has been for some time. The rapid resumption of economic activity has, however, brought its own issues. Global supply chains have felt the strain, with shipping rates rising sharply and delays to the delivery of many goods. Commodity prices have risen and tightening labour markets have led to wage rises in a number of areas. Concerns around inflation have therefore increased and, although some supply chain effects will be transitory, there is every chance of more sustained price pressures than we have seen for some time. The ability of companies to manage these cost pressures will have a significant bearing on profit trends in 2022.

 

So far, central banks have continued with loose monetary policy and low interest rates. However, there are signs of this changing and commentary from central banks has flagged rate rises on the horizon. The UK has been exposed to all of these economic changes. High vaccination rates and substantial consumer savings have led to a jump in activity, while supply chain issues and labour market tightness have likely been further increased by the exit from the EU. After a decade of falling interest rates and low inflation we should therefore be alive to a change in direction and the resultant potential impact on equity market valuations.

 

Despite these concerns, the economic background has been generally supportive for UK equities, with the recovery in earnings outweighing the impact of inflation and higher bond yields on valuations. The FTSE All-Share Index benchmark produced a total return of 8.0% in the six-month period, with the best performing sectors being energy (+20%) and healthcare (+19%). It is rare for these two sectors to both outperform simultaneously, but this market leadership reflects the rising oil price combined with a more defensive skew in the market through the summer as concerns around the effect of the Delta variant of Covid-19 increased.

 

Investment Performance

Over the first half of the financial year the Company's net asset value ("NAV") increased by 12.3% on a total return basis, outperforming the total return from the FTSE All-Share Index by 4.3%. The equity portfolio delivered positive relative performance, returning 12.0%, while the preference share portfolio returned 7.9%. By sector, the Company benefited from strong relative performance in consumer discretionary, financials and real estate holdings, offset by weaker relative performance from the portfolio's exposure to telecoms and industrials.

 

The greatest positive contributor to performance on a single stock basis was Sirius Real Estate which rose in value by 50% in the period. The company continued to grow rental income steadily and improved its balance sheet position through a successful bond issue. The German market, on which Sirius is focused, normalised during the period and the premium to NAV for its shares increased.

 

The next greatest positive contribution came from online gambling firm Entain, which rose by 40%. Entain has continued to trade well, posting growing revenues and with its US joint venture with MGM winning market share in the fast-growing US sports gaming market. At the end of the period Entain was subject to a bid from rival company Draft Kings. Although a final offer was not made in this case due to the complexity of the proposed transaction, Entain has continued to trade well and the Investment Manager continues to see upside to the shares.

 

Another strong performer was John Laing, which was sold to a private equity firm during the period. We have seen a range of UK companies being sold in the past six months as positive economic data and cheap valuations make the market attractive for acquirers.

 

The positive rebound in the UK economy could also be seen in a number of domestic industrial names. Morgan Sindall, which provides office fit-out work and construction, delivered a 38% return after being added to the portfolio, while Howden Joinery returned 27% as consumer demand for kitchens remained strong.

 

Finally, the portfolio also benefitted from strong performance from the holding in Aberdeen Smaller Companies Income Trust, which increased in value by 26%.

 

The greatest detractors from relative performance in the period were large companies that are not held within the portfolio and which performed well: Glencore, Relx, Ashtead and Experian all delivered strong returns in the period and therefore detracted from relative performance. In each case, the Investment Manager sees either a lack of income or quality as a reason not to hold these companies.

 

Of the companies held in the portfolio, only two disappointed notably during the period. Both Standard Chartered and Ashmore are financial companies exposed to emerging markets. As emerging markets, and especially China, performed poorly through the summer these two stocks lagged the market, with Standard Chartered falling 13% and Ashmore 15%. In the Investment Manager's view both companies are undervalued and offer exposure to a region with strong growth potential, and remain attractive on a longer-term view.

 

Portfolio Activity

During the period, the Investment Manager added eight new positions to the portfolio and exited four. The imbalance reflects a number of attractive opportunities to enhance the income generated by the portfolio. Overall, there has been a mild skew to add some more value to the portfolio and also some leverage to improving economic growth and a higher interest rate outlook, hence a number of new positions in banks and UK domestic names.

 

Electrocomponents is a distributor and supplier of electrical components to industry. It has delivered a strong track record of earnings growth over time, building customer loyalty through the breadth and depth of its product offering. The company also has the ability to accelerate growth through acquisitions and delivers a reasonable yield.

 

Balfour Beaty was added following the exit of John Laing, maintaining exposure to UK infrastructure investment which the Investment Manager sees as an attractive area given the point in the economic cycle. Government support for spending is likely to give higher visibility on projects and revenue than has been seen for some time and the pipeline should support mid-single-digit earnings growth on an attractive price/earnings multiple. The headline yield is around market level but the potential for growth and special dividends makes it attractive for the portfolio.

 

Bridgepoint was another new addition that maintains some exposure in the portfolio to private markets. It is a leading investor in private growth businesses which listed on the UK market earlier this year. It gives access to a higher growth part of the market with potential for an above market cash return over time.

 

Nordea Bank is a Swedish listed bank. It has come through the Covid-19 pandemic with a strengthened capital position and is now able to return material capital to shareholders over the next few years. Combined with a high return on capital for the sector and exposure to a rising interest rate environment, this makes it attractive for income.

 

The Investment Manager also initiated a position in a second European bank, Bawag, which is listed in Austria and focused on Central and Eastern Europe. The bank is a high return business and has grown through acquisitions, yet also sits with a large amount of excess capital, allowing for a period of elevated distributions which makes it attractive for income investing.

 

A number of additions to the portfolio looked to increase the portfolio's exposure to the UK domestic economy as it rebounds from the pandemic. OneSavingsBank ("OSB") is a UK lender specialising in loans to professional landlords. The area it operates in results in the bank earning a higher return on capital than large scale UK banks. It should benefit from the recovery in the UK economy and a tight property market. Redrow is a UK housebuilder and offers similar exposure to UK growth. The business is cash generative and attractively valued compared to peers, with an above market level dividend yield. With the housing market remaining tight and continued demand for new-build properties, the Investment Manager has a positive outlook for the sector.

 

The final new position was in Drax. Drax is a UK power producer, with attractive positioning in the near term as it is a beneficiary of high energy costs, and particularly UK natural gas prices. In the longer term, Drax is attractive due to its shift to generate power using biomass which, when combined with a carbon capture scheme, allows it to generate negative carbon emissions.

 

The exits from the portfolio fell into two parts: Either companies which were bid for and where the Investment Manager took profits, or where the Investment Manager saw them as fully valued after outperformance and chose to move on. In the first category, Avast and John Laing received bids. In the second category, Londonmetric Property and Dechra Pharmaceuticals both performed well and, with less upside, were sold.

 

Investment Income

The revenue earnings per share for the period were 7.21p, which compares to 6.18p for the equivalent period last year. Across the portfolio there have been increases in investment income. This partially reflects the resumption of dividends by companies after the pandemic impacted shareholder returns last year. Companies generally have a more confident outlook, while regulatory barriers to payments, for example in the banking sector, have now been lifted.

 

By company, there were meaningful increases in dividends from BHP and Rio Tinto, which have benefited from a period of particularly high iron ore prices. In the energy sector, Diversified Energy has continued to grow its dividend and BP and Royal Dutch Shell have increased their dividends after cutting them sharply in 2020. Banks in general have come out of the pandemic with a high level of capital and, after suspending dividend payments, are able to return excess capital this year. This has largely come back to shareholders in the form of buybacks, but recent additions to the portfolio, Bawag and Nordea Bank, have enhanced overall income generation.

 

Dividends

A first interim dividend of 3.2p per Ordinary share in respect of the year ending 31 March 2022 (2021: first interim dividend - 3.0p) was paid on 29 October 2021. The Board declares a second interim dividend of 3.2p per Ordinary share (2021: second interim dividend - 3.0p), payable on 28 January 2022 to shareholders on the register at close of business on 7 January 2022.

 

Subject to unforeseen circumstances, it is proposed to pay a further interim dividend of 3.2p per Ordinary share in respect of the financial year and, as in previous years, the Board will decide on the level of final dividend having reviewed the full year's results, taking into account the outcome of the revenue account for the year and the general outlook for the portfolio's investment income at that time. However, it is the Board's current intention that the final dividend will be no less than 4.2p per Ordinary share (2021: 4.2p), resulting in a total dividend for the year of at least 13.8p per Ordinary share (2021: 13.2p).

 

Gearing

The Company's gearing level (net of cash) was 20.7% as at 30 September 2021 compared to 16.5% at the start of the period. There were no changes to the Company's borrowing arrangements during the period, with £19 million of the Company's £20 million facility being drawn down at the period end. £9 million of this amount continues to be drawn down on a short-term basis through a revolving credit facility and can be repaid without incurring any financial penalties. The facility matures in September 2022.

 

As in previous years, the Board takes the view that the borrowings are notionally invested in the less volatile fixed income part of the portfolio which generates a high level of income, giving the Investment Manager greater ability to invest in a range of equity stocks, some with higher yields but other strongly growing businesses with much lower yields but with the prospect of stronger growth. This combination means that the Company can achieve a high level of dividend but also deliver some capital appreciation to shareholders.

 

Outlook

Going into 2022, the global economy faces a number of headwinds which are likely to result in growth slowing when compared with 2021. These include an economic slowdown in China and some degree of interest rate normalisation across the globe as many central banks have already signalled a more hawkish stance going forward. In addition, the outlook for the next six months is clouded to some extent by the impact of Covid-19 as we go through the winter period, including the recently discovered Omicron variant. It seems quite possible that we will see continued rising case numbers and there is the potential for increased restrictions being imposed in the UK and elsewhere at some stage although renewed lockdowns in the UK appear unlikely at present. Any measures that would inhibit the current growth trajectory would clearly be taken negatively by financial markets and does therefore create a short-term risk. Provided lockdowns can be avoided, the economy looks in good health and activity is likely to remain high with good economic growth prospects into 2022, although we should expect to see more commentary on cost and wage inflation and its impact on company earnings. This creates a risk to the earnings outlook which, combined with the likely start of the process of normalisation of interest rates, may restrict the upside in equity valuations.

 

The defensive nature of the portfolio should provide protection against too much downside and the Investment Manager continues to see plenty of upside potential for the companies in the portfolio. Banks will be significant beneficiaries of any higher rates, for example, and, more broadly, those companies that can pass through cost inflation to clients will benefit from revenue growth. This latter ability is something the Investment Manager increasingly looks for when they assess the quality of companies in the portfolio. Importantly, the Investment Manager also sees continued potential for income growth from the portfolio after the dividend cuts of 2020 are unwound. This combination should give confidence in the future prospects from the portfolio and for the Company overall.

 

 

Robert Talbut

Chairman

2 December 2021

 

 

OTHER MATTERS

 

Directors' Responsibility Statement

The Directors are responsible for preparing the Half Yearly Financial Report in accordance with applicable law and regulations. The Directors confirm that to the best of their knowledge:

 

- the condensed set of financial statements within the Half Yearly Financial Report has been prepared in accordance with IAS 34 'Interim Financial Reporting'; and

- the Interim Board Report (constituting the Interim Management Report) includes a fair review of the information required by rules 4.2.7R of the Disclosure Guidance and Transparency Rules (being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year) and 4.2.8R (being related party transactions that have taken place during the first six months of the financial year and that have materially affected the financial position of the Company during that period; and any changes in the related party transactions described in the last Annual Report that could so do).

 

Principal and Emerging Risks and Uncertainties

The Board regularly reviews the principal and emerging risks and uncertainties faced by the Company together with the mitigating actions it has established to manage the risks. These are set out within the Strategic Report contained within the Annual Report for the year ended 31 March 2021 and comprise the following risk headings:

 

- Strategic objectives and investment policy

- Investment performance

- Failure to maintain, and grow the dividend over the longer term

- Widening of discount

- Gearing

- Regulatory obligations

- Operational

- Exogenous risks such as health, social, financial and geo-political

 

In addition to these risks, the Board is conscious of the continuing impact on the global economy and financial markets caused by the Covid-19 pandemic which emerged in early 2020. The Board considers that this is a risk that could have further implications for financial markets and the operating environment of the Company.

 

In all other respects, the Company's principal and emerging risks and uncertainties have not changed materially since the date of the Annual Report and are not expected to change materially for the remaining six months of the Company's financial year.

 

Going Concern

The Company's assets consist mainly of equity shares in companies listed on the London Stock Exchange. The Board has performed stress testing and liquidity analysis on the portfolio and considers that, in most circumstances, including in the current market environment, the Company's investments are realisable within a short timescale.

 

 

The Board has set limits for borrowing and regularly reviews actual exposures, cash flow projections and compliance with banking covenants, including the headroom available. The Company has a £20 million loan facility which matures in September 2022. £9 million of this amount is drawn down on a short-term basis through a revolving credit facility and can be repaid without incurring any financial penalties.

 

Having taken these factors into account, the Directors believe that the Company has adequate resources to continue in operational existence for the foreseeable future and has the ability to meet its financial obligations as they fall due for the period to 2 December 2022, which is at least twelve months from the date of approval of this Report. For these reasons, they continue to adopt the going concern basis of accounting in preparing the financial statements.

 

On behalf of the Board

Robert Talbut

Chairman

2 December 2021

 

 

DISTRIBUTION OF ASSETS AND LIABILITIES

 

Valuation at

Movement during the period

Valuation at

31 March 2021

Purchases

Sales

Gains

30 September 2021

£'000

%

£'000

£'000

£'000

£'000

%

Listed investments

Equities

68,058

84.2

11,442

(6,549)

6,356

79,307

89.6

Preference shares

25,487

31.5

-

-

1,375

26,862

30.4

______

______

______

______

______

______

______

Total investments

93,545

115.7

11,442

(6,549)

7,731

106,169

120.0

Current assets

6,642

8.2

1,565

1.7

Current liabilities

(9,331)

(11.5)

(19,228)

(21.7)

Non-current liabilities

(9,999)

(12.4)

-

-

______

______

______

______

Net assets

80,857

100.0

88,506

100.0

______

______

______

______

Net asset value per Ordinary share

262.4p

287.0p

______

______

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

 

 30 September 2021

 (unaudited)

 Revenue

 Capital

 Total

Note

 £'000

 £'000

 £'000

Gains on investments at fair value

-

7,739

7,739

Currency gains/(losses)

-

6

6

Investment income

Dividend income

2,448

-

2,448

Stock dividends

164

-

164

Traded option premiums

29

-

29

_______

_______

_______

2,641

7,745

10,386

_______

_______

_______

Expenses

Management fee

(106)

(106)

(212)

Administrative expenses

(212)

-

(212)

Finance costs

(66)

(65)

(131)

_______

_______

_______

(384)

(171)

(555)

_______

_______

_______

Profit before taxation

2,257

7,574

9,831

Taxation

2

(34)

-

(34)

_______

_______

_______

Profit attributable to equity holders

2,223

7,574

9,797

_______

_______

_______

Earnings per Ordinary share (pence)

4

7.21

24.59

31.80

_______

_______

_______

The Company does not have any income or expense that is not included in the profit for the period, and therefore the profit for the period is also the "Total comprehensive income for the period", as defined in IAS 1 (revised).

The total column of this statement represents the Condensed Statement of Comprehensive Income of the Company, prepared in accordance with IFRS. The revenue and capital columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

All items in the above statement derive from continuing operations.

The accompanying notes are an integral part of the financial statements.

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME (Cont'd)

 

 30 September 2020

 (unaudited)

 Revenue

 Capital

 Total

Note

 £'000

 £'000

 £'000

Gains on investments at fair value

-

6,943

6,943

Currency gains/(losses)

-

7

7

Investment income

Dividend income

2,153

-

2,153

Stock dividends

49

-

49

Traded option premiums

88

-

88

_______

_______

_______

2,290

6,950

9,240

_______

_______

_______

Expenses

Management fee

(92)

(92)

(184)

Administrative expenses

(201)

-

(201)

Finance costs

(68)

(67)

(135)

_______

_______

_______

(361)

(159)

(520)

_______

_______

_______

Profit before taxation

1,929

6,791

8,720

Taxation

2

(26)

-

(26)

_______

_______

_______

Profit attributable to equity holders

1,903

6,791

8,694

_______

_______

_______

Earnings per Ordinary share (pence)

4

6.18

22.06

28.24

_______

_______

_______

 

 

CONDENSED STATEMENT OF COMPREHENSIVE INCOME (Cont'd)

 

31 March 2021

(audited)

 Revenue

 Capital

 Total

Note

 £'000

 £'000

 £'000

Gains on investments at fair value

-

17,514

17,514

Currency gains/(losses)

-

(5)

(5)

Investment income

Dividend income

4,278

-

4,278

Stock dividends

75

-

75

Traded option premiums

_______

_______

_______

4,529

17,509

22,038

_______

_______

_______

Expenses

Management fee

(189)

(190)

(379)

Administrative expenses

(358)

-

(358)

Finance costs

(132)

(132)

(264)

_______

_______

_______

(679)

(322)

(1,001)

_______

_______

_______

Profit before taxation

3,850

17,187

21,037

Taxation

2

(54)

-

(54)

_______

_______

_______

Profit attributable to equity holders

3,796

17,187

20,983

_______

_______

_______

Earnings per Ordinary share (pence)

4

12.33

55.82

68.15

_______

_______

_______

 

 

CONDENSED BALANCE SHEET

 

As at

As at

As at

30 September 2021

30 September 2020

31 March2021

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

Non-current assets

Equities

79,307

59,914

68,058

Preference shares

26,862

24,243

25,487

_______

_______

_______

Securities at fair value

106,169

84,157

93,545

_______

_______

_______

Current assets

Accrued income and prepayments

895

721

988

Cash and cash equivalents

670

4,863

5,654

_______

_______

_______

1,565

5,584

6,642

_______

_______

_______

Creditors: amounts falling due within one year

Trade and other payables

(229)

(335)

(331)

Short-term borrowings

(18,999)

(9,000)

(9,000)

_______

_______

_______

(19,228)

(9,335)

(9,331)

_______

_______

_______

Net current liabilities

(17,663)

(3,751)

(2,689)

_______

_______

_______

Total assets less current liabilities

88,506

80,406

90,856

Non-current liabilities

Long-term borrowings

-

(9,998)

(9,999)

_______

_______

_______

Net assets

88,506

70,408

80,857

_______

_______

_______

Share capital and reserves

Called-up share capital

6

15,460

15,447

15,447

Share premium account

21,109

21,052

21,052

Capital reserve

7

45,415

27,445

37,841

Revenue reserve

6,522

6,464

6,517

_______

_______

_______

Equity shareholders' funds

88,506

70,408

80,857

_______

_______

_______

Net asset value per Ordinary share (pence)

5

287.01

228.48

262.41

_______

_______

_______

The accompanying notes are an integral part of the financial statements.

 

 

CONDENSED STATEMENT OF CHANGES IN EQUITY

 

Six months ended 30 September 2021 (unaudited)

Share

Share

premium

Capital

Revenue

capital

account

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

As at 31 March 2021

15,447

21,052

37,841

6,517

80,857

Issue of Ordinary shares

13

57

-

-

70

Profit for the period

-

-

7,574

2,223

9,797

Equity dividends

-

-

-

(2,218)

(2,218)

_______

_______

_______

_______

_______

As at 30 September 2021

15,460

21,109

45,415

6,522

88,506

_______

_______

_______

_______

_______

Six months ended 30 September 2020 (unaudited)

Share

Share

premium

Capital

Revenue

capital

account

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

As at 31 March 2020

15,435

21,005

20,654

6,770

63,864

Issue of Ordinary shares

12

47

-

-

59

Profit for the period

-

-

6,791

1,903

8,694

Equity dividends

-

-

-

(2,209)

(2,209)

_______

_______

_______

_______

_______

As at 30 September 2020

15,447

21,052

27,445

6,464

70,408

_______

_______

_______

_______

_______

Year ended 31 March 2021 (audited)

Share

Share

premium

Capital

Revenue

capital

account

reserve

reserve

Total

£'000

£'000

£'000

£'000

£'000

As at 31 March 2020

15,435

21,005

20,654

6,770

63,864

Issue of Ordinary shares

12

47

-

-

59

Profit for the year

-

-

17,187

3,796

20,983

Equity dividends

-

-

-

(4,049)

(4,049)

_______

_______

_______

_______

_______

As at 31 March 2021

15,447

21,052

37,841

6,517

80,857

_______

_______

_______

_______

_______

 

 

CONDENSED CASH FLOW STATEMENT

 

Six months ended

Six months ended

Yearended

30 September 2021

30 September 2020

31 March2021

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Net cash inflow from operating activities

Dividend income received

2,561

2,302

4,105

Options premium received

42

106

172

Management fee paid

(299)

(97)

(281)

Other cash expenses

(226)

(189)

(353)

__________

__________

__________

Cash generated from operations

2,078

2,122

3,643

Interest paid

(143)

(136)

(252)

Overseas tax paid

(48)

(32)

(58)

__________

__________

__________

Net cash inflows from operating activities

1,887

1,954

3,333

__________

__________

__________

Cash flows from investing activities

Purchases of investments

(11,278)

(7,069)

(10,252)

Sales of investments

6,549

8,330

12,777

__________

__________

__________

Net cash (outflow)/inflow from investing activities

(4,729)

1,261

2,525

__________

__________

__________

Cash flows from financing activities

Equity dividends paid

(2,218)

(2,209)

(4,049)

Issue of Ordinary shares

70

59

59

__________

__________

__________

Net cash outflow from financing activities

(2,148)

(2,150)

(3,990)

__________

__________

__________

Net (decrease)/increase in cash and cash equivalents

(4,990)

1,065

1,868

__________

__________

__________

Reconciliation of net cash flow to movements in cash and cash equivalents

(Decrease)/increase in cash and cash equivalents as above

(4,990)

1,065

1,868

Net cash and cash equivalents at start of period

5,654

3,791

3,791

Effect of foreign exchange rate changes

6

7

(5)

__________

__________

__________

Cash and cash equivalents at end of period

670

4,863

5,654

__________

__________

__________

Non-cash transactions during the period comprised stock dividends of £164,000 (30 September 2020 - £49,000; 31 March 2021 - £75,000).

 

 

Notes to the Accounts

For the six months ended 30 September 2021

 

1.

Accounting policies - Basis of accounting. The condensed interim financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) 34 'Interim Financial Reporting', as adopted by the International Accounting Standards Board (IASB), and interpretations issued by the International Financial Reporting Interpretations Committee of the IASB (IFRIC). They have also been prepared using the same accounting policies applied for the year ended 31 March 2021 financial statements, which was prepared in accordance with International Financial Reporting Standards (IFRS) and received an unqualified audit report.

The financial statements have been prepared on a going concern basis. In accordance with the Financial Reporting Council's guidance on 'Going Concern and Liquidity Risk', the Directors have undertaken a review of the Company's assets which primarily consist of a diverse portfolio of listed equity shares and in most circumstances, are realisable within a very short timescale.

 

2.

Taxation. The taxation charge for the period represents withholding tax suffered on overseas dividend income.

 

3.

Dividends. The following table shows the revenue for each period less the dividends declared in respect of the financial period to which they relate.

Six months ended

Six months ended

Year ended

30 September 2021

30 September 2020

31 March 2021

£'000

£'000

£'000

Revenue

2,223

1,903

3,796

Dividends declared

(1,972) A

(1,848) B

 

(4,065) C

 

__________

__________

__________

251

55

(269)

__________

__________

__________

A Dividends declared relate to first two interim dividends (3.20p each) in respect of the financial year 2021/22.

B Dividends declared relate to first two interim dividends (3.00p each) in respect of the financial year 2020/21.

C First three interim dividends (3.00p each) and the final dividend (4.20p) declared in respect of the financial year 2020/21.

 

4.

Earnings per Ordinary share

Six months ended

Six months ended

Year ended

30 September 2021

30 September 2020

31 March 2021

£'000

£'000

£'000

Returns are based on the following figures:

Revenue return

2,223

1,903

3,796

Capital return

7,574

6,791

17,187

__________

__________

__________

Total return

9,797

8,694

20,983

__________

__________

__________

Weighted average number of Ordinary shares in issue

30,804,963

30,781,875

30,788,210

__________

__________

__________

 

5.

Net asset value per Ordinary share. The net asset value per Ordinary share and the net asset values attributable to Ordinary shareholders at the period end were as follows:

As at

As at

As at

30 September 2021

30 September 2020

31 March 2021

(unaudited)

(unaudited)

(audited)

Net assets per Condensed Balance Sheet (£'000)

88,506

70,408

80,857

3.5% Cumulative Preference shares of £1 each (£'000)

(50)

(50)

(50)

__________

__________

__________

Attributable net assets (£'000)

88,456

70,358

80,807

__________

__________

__________

Number of Ordinary shares in issue

30,819,580

30,794,580

30,794,580

__________

__________

__________

Net asset value per Ordinary share (p)

287.01

228.48

262.41

__________

__________

__________

The Company has a policy of calculating the net asset value per Ordinary share based on net assets less an amount due to holders of 3.5% Cumulative Preference shares of £1 each equating to £1 per share (£50,000), divided by the number of Ordinary shares in issue.

 

6.

Called up share capital

30 September 2021

30 September 2020

31 March 2021

Number

£'000

Number

£'000

Number

£'000

Allotted, called up and fully paid Ordinary shares of 50 pence each:

Balance brought forward

30,794,580

15,397

30,769,580

15,385

30,769,580

15,385

Ordinary shares issued

25,000

13

25,000

12

25,000

12

__________

_______

__________

_______

__________

_______

Balance carried forward

30,819,580

15,410

30,794,580

15,397

30,794,580

15,397

__________

_______

__________

_______

__________

_______

Allotted, called up and fully paid 3.5% Cumulative Preference shares of £1 each

Balance brought forward and carried forward

50,000

50

50,000

50

50,000

50

_______

_______

_______

15,460

15,447

15,447

_______

_______

_______

During the six months ended 30 September 2021 the Company issued 25,000 Ordinary shares of 50p each (six months ended 30 September 2020 - 25,000; year ended 31 March 2021 - 25,000) for proceeds of £70,000 (six months ended 30 September 2020 - £59,000; year ended 31 March 2021 - £59,000).

 

7.

Capital reserve. The capital reserve reflected in the Condensed Balance Sheet at 30 September 2021 includes unrealised gains of £19,147,000 (30 September 2020 - gains of £2,742,000; 31 March 2021 - gains of £13,165,000) which relate to the revaluation of investments held at the reporting date. The balance relates to realised gains of £26,268,000 (30 September 2020 - £24,703,000; 31 March 2021 - £24,676,000).

 

8.

Analysis of changes in financial liabilities

Six months ended

Six months ended

Year ended

30 September 2021

30 September 2020

31 March 2021

£'000

£'000

£'000

Opening balance at 1 April

(18,999)

(18,998)

(18,998)

Cashflow

(70)

(59)

(59)

Other movements A

 

70

59

58

__________

_______

__________

Closing balance

(18,999)

(18,998)

(18,999)

__________

_______

__________

A The other movements represent the proceeds from the issue of Ordinary shares and the amortisation of the loan arrangement fees.

The Company has an agreement with Scotiabank Europe PLC to provide a loan facility to 20 September 2022 for up to £20,000,000. A £10,000,000 fixed rate loan was drawn down on 20 September 2019 at a rate of 1.706%. This rate is fixed until maturity on 20 September 2022. In addition, at the period end £9,000,000 had been drawn down on a revolving basis at an all-in interest rate of 0.94688%, maturing on 20 October 2021. At the date of this Report, £9,000,000 was drawn down on a revolving basis at an all-in interest rate of 0.9796%.

 

9.

Transactions with the Manager. The Company has an agreement with Aberdeen Standard Fund Managers Limited ("ASFML") for the provision of management, secretarial, accounting and administration services and for the carrying out of promotional activities and saving scheme services in relation to the Company.

The management fee is based on 0.45% per annum up to £100 million and 0.40% per annum over £100 million, by reference to the net assets of the Company and including any borrowings up to a maximum of £30 million, and excluding commonly managed funds, calculated monthly and paid quarterly. The fee is allocated 50% to revenue and 50% to capital. The agreement is terminable on not less than six months' notice. The total of the fees paid and payable during the period to 30 September 2021 was £212,000 (30 September 2020 - £184,000; 31 March 2021 - £379,000) and the balance due to ASFML at the period end was £107,000 (30 September 2020 - £184,000; 31 March 2021 - £195,000). The Company held an interest in a commonly managed fund, Aberdeen Smaller Companies Income Trust PLC, in the portfolio during the period to 30 September 2021 (30 September 2020 and 31 March 2021 - same). The value attributable to this holding is excluded from the calculation of the management fee payable by the Company.

The management agreement with ASFML also provides for the provision of promotional activities, which ASFML has delegated to Aberdeen Asset Managers Limited. The total fees paid and payable in relation to promotional activities were £24,000 (30 September 2020 - £28,000; 31 March 2021 - £48,000) and the balance due to ASFML at the period end was £12,000 (30 September 2020 - £28,000; 31 March 2021 - £12,000). The Company's management agreement with ASFML also provides for the provision of company secretarial and administration services to the Company; no separate fee is charged to the Company in respect of these services, which have been delegated to Aberdeen Asset Management PLC.

 

10.

Segmental information. For management purposes, the Company is organised into one main operating segment, which invests in equity securities and debt instruments. All of the Company's activities are interrelated, and each activity is dependent on the others. Accordingly, all significant operating decisions are based upon analysis of the Company as one segment. The financial results from this segment are equivalent to the financial statements of the Company as a whole.

 

11.

Fair value hierarchy. IFRS 13 'Fair Value Measurement' requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

Level 2: inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly (ie as prices) or indirectly (ie derived from prices); and

Level 3: inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The financial assets and liabilities measured at fair value in the Condensed Balance Sheet are grouped into the fair value hierarchy as follows:

Level 1

Level 2

Level 3

Total

At 30 September 2021

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted investments

a)

106,169

-

-

106,169

Financial liabilities at fair value through profit or loss

Derivatives

b)

-

(10)

-

(10)

_______

_______

_______

_______

Net fair value

106,169

(10)

-

106,159

_______

_______

_______

_______

Level 1

Level 2

Level 3

Total

At 30 September 2020

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted investments

a)

84,157

-

-

84,157

Financial liabilities at fair value through profit or loss

Derivatives

b)

-

(23)

-

(23)

_______

_______

_______

_______

Net fair value

84,157

(23)

-

84,134

_______

_______

_______

_______

Level 1

Level 2

Level 3

Total

At 31 March 2021

Note

£'000

£'000

£'000

£'000

Financial assets at fair value through profit or loss

Quoted investments

a)

93,545

-

-

93,545

Financial liabilities at fair value through profit or loss

Derivatives

b)

-

-

-

-

_______

_______

_______

_______

Net fair value

93,545

-

-

93,545

_______

_______

_______

_______

a)

Quoted investments. The fair value of the Company's quoted investments has been determined by reference to their quoted bid prices at the reporting date. Quoted investments included in Fair Value Level 1 are actively traded on recognised stock exchanges.

b)

Derivatives. The fair value of the Company's investments in Exchange Traded Options has been determined using observable market inputs on an exchange traded basis although not actively traded and therefore have been classed as Level 2.

The fair value of the Company's investments in Over the Counter Options has been determined using observable market inputs other than quoted prices included within Level 2.

 

12.

The financial information contained in this Half Yearly Financial Report does not constitute statutory accounts as defined in Sections 434 - 436 of the Companies Act 2006. The financial information for the six months ended 30 September 2021 and 30 September 2020 has not been reviewed or audited by the Company's independent auditor.

The information for the year ended 31 March 2021 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the independent auditor on those accounts contained no qualification or statement under Section 498 (2), (3) or (4) of the Companies Act 2006.

 

13.

This Half Yearly Financial Report was approved by the Board on 2 December 2021.

 

 

ALTERNATIVE PERFORMANCE MEASURES

Alternative performance measures are numerical measures of the Company's current, historical or future performance, financial position or cash flows, other than financial measures defined or specified in the applicable financial framework. The Company's applicable financial framework includes IFRS and the AIC SORP. The Directors assess the Company's performance against a range of criteria which are viewed as particularly relevant for closed-end investment companies.

Total Return. NAV and share price total returns show how the NAV and share price has performed over a period of time in percentage terms, taking into account both capital returns and dividends paid to shareholders. NAV total return involves a calculation that invests the net dividend in the NAV of the Company with debt at fair value on the date on which that dividend goes ex-dividend. Share price total return involves a calculation that invests the net dividend in the share price of the Company on the date on which that dividend goes ex-dividend.

The tables below provide information relating to the NAVs and share prices of the Company on the dividend reinvestment dates during the six months ended 30 September 2021 and 30 September 2020 and assumes reinvestment of net dividends excluding transaction costs (the "Adjustment factor").

Dividend

Share

30 September 2021

rate

NAV

price

31 March 2021 (a)

262.41p

248.00p

8 April 2021

3.00p

266.85p

257.50p

8 July 2021

4.20p

275.58p

269.00p

30 September 2021 (b)

287.01p

269.50p

Adjustment factor (c)

1.026655

1.027429

__________

__________

30 September 2021 adjusted (d)=(b*c)

294.66p

276.89p

__________

__________

Total return (d/a)

+12.3%

+11.7%

__________

__________

Dividend

Share

30 September 2020

rate

NAV

price

31 March 2020 (a)

207.39p

200.50p

2 April 2020

3.00p

199.79p

188.75p

2 July 2020

4.20p

234.93p

236.00p

30 September 2020 (b)

228.48p

213.50p

__________

__________

Adjustment factor (c)

1.032956

1.033960

__________

__________

30 September 2020 adjusted (d)=(b*c)

236.01p

220.75p

__________

__________

Total return (d/a)

+13.8%

+10.1%

__________

__________

Discount to net asset value per Ordinary share. The difference between the share price and the net asset value per Ordinary share expressed as a percentage of the net asset value per Ordinary share.

30 September 2021

31 March 2021

NAV per Ordinary share (p)

a

287.01

262.41

Share price (p)

b

269.50

248.00

Discount

(a-b)/a

6.1%

5.5%

__________

__________

Dividend yield. The annual dividend divided by the share price, expressed as a percentage.

30 September 2021

31 March 2021

Annual dividend per Ordinary share (p)

a

13.20p

13.20p

Share price (p)

b

269.50p

248.00p

Dividend yield

a/b

4.9%

5.3%

__________

__________

Net gearing. Net gearing measures total borrowings less cash and cash equivalents divided by shareholders' funds, expressed as a percentage. Under AIC reporting guidance, cash and cash equivalents includes net amounts due to and from brokers at the period end as well as cash and short term deposits.

30 September 2021

31 March2021

Borrowings (£'000)

a

18,999

18,999

Cash (£'000)

b

670

5,654

Amounts due to brokers (£'000)

c

-

-

Amounts due from brokers (£'000)

d

-

-

Shareholders' funds (£'000)

e

88,506

80,857

__________

__________

Net gearing

(a-b+c-d)/e

20.7%

16.5%

__________

__________

Ongoing charges. Ongoing charges is considered to be an alternative performance measure. The ongoing charges ratio has been calculated in accordance with guidance issued by the AIC as the total of investment management fees and administrative expenses and expressed as a percentage of the average net asset values throughout the year. The ratio for 30 September 2021 is based on forecast ongoing charges for the year ending 31 March 2022.

30 September 2021

31 March2021

Investment management fees (£'000)

427

379

Administrative expenses (£'000)

399

358

__________

__________

Ongoing charges (£'000)

826

737

__________

__________

Average net assets (£'000)

87,364

73,999

__________

__________

Ongoing charges ratio (excluding look-through costs)

0.95%

1.00%

__________

__________

Look-through costs A

0.22%

0.21%

__________

__________

Ongoing charges ratio (including look-through costs)

1.17%

1.21%

__________

__________

A Costs associated with holdings in collective investment schemes as defined by the Committee of European Securities Regulators' guidelines on the methodology for the calculation of the ongoing charges figure, issued on 1 July 2010.

The ongoing charges ratio provided in the Company's Key Information Document is calculated in line with the PRIIPs regulations which, amongst other things, includes the cost of borrowings and transaction costs.

 

 

Please note that past performance is not necessarily a guide to the future and that the value of investments and the income from them may fall as well as rise. Investors may not get back the amount they originally invested

 

By order of the Board

Aberdeen Asset Management PLC

Company Secretary

2 December 2021

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FSEFMFEFSEDE
Date   Source Headline
2nd May 202412:59 pmRNSNet Asset Value(s)
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:19 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:46 pmRNSNet Asset Value(s)
12th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202411:24 amRNSCompliance with Market Abuse Regulation
11th Apr 202412:41 pmRNSNet Asset Value(s)
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20245:20 pmRNSQuarterly disclosure
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:10 amRNSTotal Voting Rights
28th Mar 20245:47 pmRNSTransaction in Own Shares
28th Mar 20242:04 pmRNSNet Asset Value(s)
28th Mar 20241:50 pmRNSDirector/PDMR Shareholding
27th Mar 20245:28 pmRNSTransaction in Own Shares
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 20245:21 pmRNSTransaction in Own Shares
26th Mar 202412:23 pmRNSNet Asset Value(s)
25th Mar 20245:35 pmRNSTransaction in Own Shares
25th Mar 20243:58 pmRNSGearing disclosure
25th Mar 202412:06 pmRNSNet Asset Value(s)
22nd Mar 20245:24 pmRNSTransaction in Own Shares
22nd Mar 202412:16 pmRNSNet Asset Value(s)
21st Mar 20245:17 pmRNSTransaction in Own Shares
21st Mar 20241:17 pmRNSNet Asset Value(s)
20th Mar 202411:45 amRNSNet Asset Value(s)
19th Mar 202412:24 pmRNSNet Asset Value(s)
18th Mar 20242:19 pmRNSGearing Disclosure
18th Mar 202411:46 amRNSNet Asset Value(s)
15th Mar 202412:22 pmRNSNet Asset Value(s)
14th Mar 20243:46 pmRNSPortfolio disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.